Taselisib 5 mg | 99.46%
TargetMol
Taselisib is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity.
More Information Supplier PageTaselisib
Search Results
Taselisib 50 mg | 99.46%
TargetMol
Taselisib is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity.
More Information Supplier PageTaselisib
Taselisib 10 mg | 99.46%
TargetMol
Taselisib is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity.
More Information Supplier PageTaselisib
(S)-P7C3-OMe 5 mg | 99.61%
TargetMol
(S)-P7C3-OMe is a methoxy derivative of parent compound P7C3, an aminopropyl carbazole that exhibits antidepressant and neuroprotective activities.
More Information Supplier Page(S)-P7C3-OMe
(S)-P7C3-OMe 50 mg | 99.61%
TargetMol
(S)-P7C3-OMe is a methoxy derivative of parent compound P7C3, an aminopropyl carbazole that exhibits antidepressant and neuroprotective activities.
More Information Supplier Page(S)-P7C3-OMe
(S)-P7C3-OMe 2 mg | 99.61%
TargetMol
(S)-P7C3-OMe is a methoxy derivative of parent compound P7C3, an aminopropyl carbazole that exhibits antidepressant and neuroprotective activities.
More Information Supplier Page(S)-P7C3-OMe
(S)-P7C3-OMe 25 mg | 99.61%
TargetMol
(S)-P7C3-OMe is a methoxy derivative of parent compound P7C3, an aminopropyl carbazole that exhibits antidepressant and neuroprotective activities.
More Information Supplier Page(S)-P7C3-OMe
U-104 10 mg | 100.00%
TargetMol
U-104 (NSC-213841) is an effective carbonic anhydrase (CA) inhibitor for CA IX( Ki=45.1 nM) and CA XII(Ki=4.5 nM).
More Information Supplier PageU-104
U-104 25 mg | 100.00%
TargetMol
U-104 (NSC-213841) is an effective carbonic anhydrase (CA) inhibitor for CA IX( Ki=45.1 nM) and CA XII(Ki=4.5 nM).
More Information Supplier PageU-104
WHI-P258 50 mg | 99.59%
TargetMol
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK-binding negative control in the development of new therapeutics.
More Information Supplier PageWHI-P258
